RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-4135
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Details mutation: The P. berghei csp gene replaced by P. falciparum csp
Transgene
Transgene not Plasmodium: A fusion of GFP (gfp-mu3) and Luciferase Firefly (LucIAV)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
PhenotypeNo phenotype has been described
Last modified: 20 April 2017, 18:40
  *RMgm-4135
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28298290
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 676m1cl1 (RMgm-29)
Other information parent line676m1cl1 (RMgm-29) is a reference ANKA mutant line which expresses GFP-luciferase under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherVijayan A; Zavala F; Esteban M
Name Group/DepartmentDepartment of Molecular and Cellular Biology
Name InstituteCentro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC)
CityMadrid
CountrySpain
Name of the mutant parasite
RMgm numberRMgm-4135
Principal nameP.b.-P.f. CSP-FL CD8CT
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
In the mutant the endogenous P. berghei csp gene has been replaced by the P. falciparum csp gene.
This line expresses the full-length P. falciparum CS protein (3D7). In this transgenic line, a single amino acid in the CS protein region containing the sequence DYANDIEKKI was modified to incorporate the cytotoxic CD8+ T cell epitope DYENDIEKKI. This epitope is not found in the 3D7 strain, but is present in other P. falciparum  isolates (such as 7G8 and T4)

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
Normal development throughout the complete life cycle showing complementation of P. berghei CSP by P. falciparum CSP

Additional information

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Short description of the mutationThe P. berghei csp gene replaced by P. falciparum csp
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitenot available
Promoter of the selectable markernot available
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationA P. berghei transgenic parasite was generated expressing the full-length P. falciparum CS protein (3D7). In this transgenic line, a single amino acid in the CS protein region containing the sequence DYANDIEKKI was modified to incorporate the cytotoxic CD8+ T cell epitope DYENDIEKKI. This epitope is not found in the 3D7 strain, but is present in other P. falciparum isolates (such as 7G8 and T4). The full-length PfCS with the P. berghei native signal sequence was cloned into the CS locus of GFP-luciferase P. berghei ANKA.
To develop the chimeric line P.b.-P.f. CSP-FL CD8CT, a 784-bp restriction fragment encompassing base pairs 246 to 1029 of the P. berghei-P. falciparum CSP NT csp chimeric gene was excised from the plasmid pIC-CSPPfNT (37) using restriction enzymes BbsI and PacI (New England Biolabs). This portion was replaced with a 943-bp fragment, which was released using the same restriction enzymes as for the pHZ-PfCSP plasmid. The csp gene (1188 bp) in the resulting plasmid, pIC-CSPfFL-CD8CT, consists of a full-length P. falciparum 3D7 CSP in which the signal sequence was replaced with that from the P. berghei CSP (base pairs 1 to 69). In addition, a single base pair in the plasmid pIC-CSPfFL-CD8CT CS gene was replaced to incorporate a cytotoxic epitope not present in the P. falciparum 3D7 strain. This change was introduced in base pair 1079 by site-directed mutagenesis using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies). We then excised the CS gene from pIC-CSPfFL-CD8CT as a KpnI-PacI fragment and inserted it into the transfection plasmid pR-CSPfFL-CD8CT. XhoI and KasI were used to linearize pR-CSPfFL-CD8CT prior to transfection of GFP-luciferase P. berghei ANKA parasites.


reference 37:
Espinosa DA, Gutierrez GM, Rojas-López M, Noe AR, Shi L, Tse S-W, Sinnis P, Zavala F. 2015.
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of
Protective Antibodies. The Journal of infectious diseases 212:1111-1119.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameA fusion of GFP (gfp-mu3) and Luciferase Firefly (LucIAV)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4